Peter J. Nelson

18.2k total citations
252 papers, 13.8k citations indexed

About

Peter J. Nelson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Peter J. Nelson has authored 252 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 89 papers in Immunology and 84 papers in Molecular Biology. Recurrent topics in Peter J. Nelson's work include Chemokine receptors and signaling (36 papers), T-cell and B-cell Immunology (34 papers) and Renal Diseases and Glomerulopathies (32 papers). Peter J. Nelson is often cited by papers focused on Chemokine receptors and signaling (36 papers), T-cell and B-cell Immunology (34 papers) and Renal Diseases and Glomerulopathies (32 papers). Peter J. Nelson collaborates with scholars based in Germany, United States and Switzerland. Peter J. Nelson's co-authors include Alan M. Krensky, Detlef Schlöndorff, Stephan Segerer, Christian Weber, Kim S. C. Weber, Detlef SchloCombining Diaeresisndorff, Christiane J. Bruns, Irwin H. Gelman, Clemens D. Cohen and Matthias Kretzler and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter J. Nelson

249 papers receiving 13.6k citations

Peers

Countries citing papers authored by Peter J. Nelson

Since Specialization

Citations

This map shows the geographic impact of Peter J. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Nelson more than expected).

Fields of papers citing papers by Peter J. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Nelson. The network helps show where Peter J. Nelson may publish in the future.

Co-authorship network of co-authors of Peter J. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Nelson. A scholar is included among the top collaborators of Peter J. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Nelson. Peter J. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice 2023 ·Frontiers in Immunology ·(unknown), Julian A. Marschner, Martin Klaus, (unknown), Chenyu Li, Manga Motrapu, Christoph Walz, Maria Lucia Angelotti, Giulia Antonelli, Maria Elena Melica, Letizia De Chiara, Roberto Semeraro, Peter J. Nelson, Hans‐Joachim Anders	7
2	Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival 2022 ·Cells ·(unknown), (unknown), (unknown), Tobias Straub, (unknown), Martin Irmler, (unknown), Florian Büttner, Elke Schaeffeler, Stefan Winter, Matthias Schwab, Peter J. Nelson, Elfriede Noeßner	10
3	Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter ( NIS ) Gene Therapy Improves Survival of Glioblastoma-bearing Mice 2022 ·Clinical Cancer Research ·(unknown), (unknown), Yang Han, Kathrin A. Schmohl, (unknown), Christian Zach, Roland E. Kälin, Gabriele Multhoff, Matthias Eiber, Franz Schilling, Rainer Glaß, Wolfgang Weber, Ernst Wagner, Peter J. Nelson, Christine Spitzweg	11
4	Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter ( NIS ) Gene 131I Therapy 2019 ·Clinical Cancer Research ·Christina Schug, (unknown), Wolfgang Sievert, (unknown), (unknown), Kathrin A. Schmohl, Bernadette Eberlein, Tilo Biedermann, Katja Steiger, Christian Zach, Markus Schwaiger, Gabriele Multhoff, Ernst Wagner, Peter J. Nelson, Christine Spitzweg	21
5	DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS 2018 ·Journal of the American Society of Nephrology ·Howard Trachtman, Peter J. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal K. Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth V. Lieberman, Brad A. Marder, Kevin Meyers, (unknown), Jai Radhakrishnan, Tarak Srivastava, (unknown), Vladimı́r Tesař, Olga Zhdanova, Radko Komers, (unknown)	129
6	Studies on the Biocompatibility of Poly(diethyl vinyl‐phosphonate) with a New Fluorescent Marker 2018 ·Macromolecular Rapid Communications ·(unknown), Sergei I. Vagin, Werner R. Heinz, Peter J. Nelson, Bernhard Rieger	9
7	Fluorescent Polyvinylphosphonate Bioconjugates for Selective Cellular Delivery 2018 ·Chemistry - A European Journal ·(unknown), (unknown), Elfriede Nößner, Peter J. Nelson, Ralf Huss, Bernhard Rieger	13
8	Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery 2018 ·Nanoscale ·(unknown), Peter J. Nelson, Ralf Huss, Bernhard Rieger	15
9	Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy 2017 ·Cancer Research ·Ramona Schlenker, (unknown), Matthias Leisegang, (unknown), (unknown), Svenja Rühland, Peter J. Nelson, Heinrich Leonhardt, Hartmann Harz, Susanne Wilde, Dolores J. Schendel, Wolfgang Uckert, Gerald Willimsky, Elfriede Noeßner	33
10	Precise synthesis of thermoresponsive polyvinylphosphonate-biomolecule conjugatesviathiol–ene click chemistry 2017 ·Polymer Chemistry ·(unknown), (unknown), (unknown), Peter J. Nelson, Ralf Huss, Bernhard Rieger	23
11	p53‐Dependent Senescence in Mesenchymal Stem Cells under Chronic Normoxia Is Potentiated by Low‐Dose γ‐Irradiation 2015 ·Stem Cells International ·Ines Höfig, (unknown), Michael J. Atkinson, (unknown), Peter J. Nelson, Michael Rosemann	11
12	Podoplanin increases migration and angiogenesis in malignant glioma. 2015 ·PubMed ·Stefan Grau, Fabian Trillsch, Joerg‐Christian Tonn, Roland Goldbrunner, Elfriede Noeßner, Peter J. Nelson, Irene von Luettichau	23
13	Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial 2015 ·BMC Cancer ·Hanno Nieß, Jobst C. von Einem, Michael Thomas, Marlies Michl, Martin K. Angele, Ralf Huss, Christine Günther, Peter J. Nelson, Christiane J. Bruns, Volker Heinemann	86
14	Hypoxia-Independent Gene Expression Mediated by SOX9 Promotes Aggressive Pancreatic Tumor Biology 2013 ·Molecular Cancer Research ·Peter Čamaj, (unknown), Stefan Krebs, (unknown), Helmut Blum, Karl‐Walter Jauch, Peter J. Nelson, Christiane J. Bruns	22
15	Stem Cell-Like Side Populations in Esophageal Cancer: A Source of Chemotherapy Resistance and Metastases 2013 ·Stem Cells and Development ·Yue Zhao, Qi Bao, Bettina Schwarz, Lu Zhao, Josef Mysliwietz, Joachim W. Ellwart, (unknown), Heidrun Hirner, Hanno Nieß, Peter Čamaj, Martin K. Angele, Stephanie J. Gros, Jakob R. Izbicki, Karl‐Walter Jauch, Peter J. Nelson, Christiane J. Bruns	39
16	Human Renal Cell Carcinoma Induces a Dendritic Cell Subset That Uses T-Cell Crosstalk for Tumor-Permissive Milieu Alterations 2011 ·American Journal Of Pathology ·(unknown), (unknown), Petra U. Prinz, (unknown), (unknown), Adriana Turqueti‐Neves, Josef Mysliwietz, David Anz, (unknown), (unknown), Alexander Büchner, Štefan Porubský, Sabine Siegert, Stephan Segerer, Peter J. Nelson, Elfriede Noeßner	36
17	Efficient Renal Recruitment of Macrophages and T Cells in Mice Lacking the Duffy Antigen/Receptor for Chemokines 2009 ·American Journal Of Pathology ·Volker Vielhauer, Ramanjaneyulu Allam, Maja T. Lindenmeyer, Clemens D. Cohen, Dan Draganovici, (unknown), (unknown), Peter J. Nelson, Hans‐Joachim Anders, Monika Pruenster, Antal Rot, Detlef Schlöndorff, Stephan Segerer	31
18	Loss of the ssecks/gravin/akap12 Gene Results in Prostatic Hyperplasia 2008 ·Cancer Research ·Shin Akakura, (unknown), Peter J. Nelson, Barbara A. Foster, Irwin H. Gelman	62
19	Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice 2007 ·Circulation ·Regina M. Krohn, Ute Raffetseder, Ilze Bot, Alma Zernecke, Erdenechimeg Shagdarsuren, Elisa A. Liehn, Peter J. van Santbrink, Peter J. Nelson, Erik A.L. Biessen, Peter R. Mertens, Christian Weber	87
20	A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation 2002 ·Journal of Clinical Investigation ·Hans‐Joachim Anders, Volker Vielhauer, Michael Frink, Yvonne Linde, Clemens D. Cohen, Simone M. Blattner, Matthias Kretzler, Frank Strutz, Matthias Mack, Hermann‐Josef Gröne, James Onuffer, Richard Horuk, Peter J. Nelson, Detlef Schlöndorff	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact